MDEC chief Anuar Fariz Fadzil to exit after US$44B investment push

A founder pitched me earlier this year on his semiconductor company. The deck was clean. The market was real. The technology was genuinely differentiated. The Singapore entity was properly incorporated, the cap table looked orderly, and the revenue was growing. Then I asked him three questions. Where does your intellectual property legally sit? Who owns […] The post The cross-border due diligence questions most founders cannot answer appeared first on e27.

John Ternus is reportedly restructuring Apple into a leaner, more engineering-focused company while pushing for a faster product and innovation cycle.

Sometimes, last-minute in-store shopping might be your best option.

Need fast wireless charging at a desk or on the go for your brand-new iPhone 18 Pro and Pro Max? Ugreen just launched three charging solutions for that.

Nvidia founder and CEO Jensen Huang and AMD chief Lisa Su have joined an influential advisory board at a prestigious Chinese university, placing the two key American AI tech leaders in a high-level forum known for connecting global executives with senior Chinese officials. Huang and Su were among three new members appointed to the advisory board of Tsinghua University’s School of Economics and Management (SEM), alongside Marc Pictet, senior managing partner of Swiss wealth and assets manager...

Nvidia founder and CEO Jensen Huang and AMD chief Lisa Su have joined an influential advisory board at a prestigious Chinese university, placing the two key American AI tech leaders in a high-level forum known for connecting global executives with senior Chinese officials. Huang and Su were among three new members appointed to the advisory board of Tsinghua University’s School of Economics and Management (SEM), alongside Marc Pictet, senior managing partner of Swiss wealth and assets manager...

China’s generative artificial intelligence user base surpassed 700 million at the end of June, accounting for more than half of the population as wide AI adoption pushes the technology’s penetration rate to a record high in the country. The user base data, released Tuesday by the China Internet Network Information Centre, represents an increase of 16 per cent from the end of 2025, when China had 602 million generative AI users with a penetration rate of 42.8 per cent. Question-and-answer...

Hong Kong businesses are lagging behind their mainland Chinese peers in adopting artificial intelligence, as entrenched legacy systems and a risk-averse corporate mindset slow the city’s digital transition, according to a senior executive at consultancy Accenture. Only 10 per cent of Hong Kong firms surveyed by Accenture had integrated generative AI across multiple business functions, compared with about 21 per cent of mainland enterprises, said Robert Hah, Hong Kong office lead at Accenture...

Sibol’s Pokémon UNITE campaign at the 20th Asian Games Aichi-Nagoya 2026 ended with a bronze medal after Indonesia stopped the Philippines in the semifinals at Aichi Sky Expo on Sunday. The Philippines fell 2-0 to Indonesia in the semifinal, ending its bid for a place in the gold-medal match. Despite the loss, the result gave

Anthropic has told prospective investors that it is growing at a pace few companies have matched, losing money at a scale few could survive, and building a product that could pose an existential threat to humanity. The prospectus behind what could become the largest IPO on record shows revenue rising twelvefold to nearly US$4.6 billion in 2025, […] The post Ecosystem Roundup: Anthropic’s IPO filing: 12x revenue, US$8B loss and an extinction risk appeared first on e27.

Chinese memory chip giant ChangXin Memory Technologies (CXMT) plans to invest 34.9 billion yuan (US$5.2 billion) in expansion, with a large portion of the capital going to domestic suppliers of chipmaking equipment, according to a source. The firm, listed on the Shanghai Stock Exchange’s Star Market, would spend 24.1 billion yuan on a new technology research and development project and another 10.8 billion yuan on the second phase of a wafer testing base, according to a Monday stock filing. The...

Shares of Akeso surged after British drug maker AstraZeneca moved to advance the Chinese biotech firm’s flagship cancer drug, while a new deal from US giant Merck further underscored the sector’s global momentum amid easing fears of US curbs. AstraZeneca on Tuesday announced a US$2 billion equity investment in Florida-headquartered Summit Therapeutics, which holds the exclusive rights to develop and commercialise Akeso’s immunotherapy drug ivonescimab outside China. Summit and AstraZeneca would...